Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedrine-containing dietary supplement total ban urged by Texas Department of Health.

This article was originally published in The Tan Sheet

Executive Summary

EPHEDRINE ALKALOID BAN IN DIETARY SUPPLEMENTS URGED by the Texas Department of Health in Oct. 13 comments to FDA. "Our current position, based on available scientific data, the recommendations of two medical and scientific panels, and the majority opinion of FDA's Food Advisory Committee, is that no safe level or safe conditions for use can be established for dietary supplement products containing ephedrine alkaloids," the department says.

You may also be interested in...



Ephedrine Labeling MedWatch Reference Proposed In Texas

Texas is considering amending its rules pertaining to ephedrine-containing dietary supplements sold in the state to require the toll-free number for FDA's MedWatch adverse event reporting program on product labels. This would be the first time the MedWatch number has been required on a product.

Ephedrine Labeling MedWatch Reference Proposed In Texas

Texas is considering amending its rules pertaining to ephedrine-containing dietary supplements sold in the state to require the toll-free number for FDA's MedWatch adverse event reporting program on product labels. This would be the first time the MedWatch number has been required on a product.

Ephedrine Labeling MedWatch Reference Proposed In Texas

Texas is considering amending its rules pertaining to ephedrine-containing dietary supplements sold in the state to require the toll-free number for FDA's MedWatch adverse event reporting program on product labels. This would be the first time the MedWatch number has been required on a product.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel